Board of Directors

Mr. Göran Pettersson
Mr. Göran Pettersson
Board Member and Chairman since 2015

Born: 1945.

Göran previously was Chairman in Axelar AB, Medivir AB (publ) and Dermagen AB. He was board member in Recipharm AB (publ) and Bioretec OY. Göran was board member and CEO of Meda Sverige AB (publ).  Petterson has held leading positions in AstraZeneca, KabiVitrum and Pharmacia. He holds a M. Pharm Sc. from Uppsala University and an MBA from IHM in Stockholm.

Other Assignments: Göran is deputy chairman in Mobidiag Oy and chairman in Mobidag Sverige AB. He is a board member in G. Pettersson & Partners AB, Pfizer Pensionsstiftelse I and Brf Trumslagaren 3. He is a deputy board member in Karl Jungstedt AB.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders: Yes.
Share Holding in Promore Pharma: No current holding.

Mr. Göran Linder
Mr. Göran Linder
Board Member since 2015

Born: 1962.

Göran serves as Senior Executive in several investment companies. He was previously board member in among others Transic AB, Jensen Devices AB, Airgrinder AB and Lamera AB. Göran holds an M.Sc. from the KTH Royal Institute of Technology in Stockholm.

Other Assignments: CEO and board member in Midroc New Technology AB, Midroc Invest AB and Midroc Finans AB. Board member in Powercell Sweden AB (publ), Powercell Warrants One AB, Nilsson Special Vehicles Aktiebolag (publ), Pergamum AB, Minesto AB (publ), Minesto Warrants One AB, Crunchfish AB (publ) M&J by Malin & Johanna AB and QCG Sweden AB. He is a deputy board member in Heliospectra AB (publ) och Corpower Ocean AB.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders: No.
Share Holding in Promore Pharma: No current holding.

Dr. Torsten Goesch
Dr. Torsten Goesch
Board Member since 2015

Born: 1959.

Torsten serves as Senior Executive in Rosetta Capital Limited where he is responsible for investments. He has served as board member of several biotechnology companies. Torsten has served as board member of STI Ltd and Cytochroma Ltd. He holds an M.D. and a Ph.D. from Heinrich Heine University Düsseldorf, Germany and an MBA from the Kellogg School of Management in Evanston, USA.

Other Assignments: Torsten serves as Chairman of Biosergen AS and Biosergen China JV, board member of Rosetta Capital Limited, Forward Pharma, Vistagen Pte Ltd, Dilafor AB, Dilaforette AB, Karolinska Development Invest AB, Eyesense GmbH and Dr Goesch Pharma Pte Ltd.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders: No.
Share Holding in Promore Pharma: No current holding.

Dr. Satyendra Kumar
Dr. Satyendra Kumar
Board Member since 2016

Born: 1954

Satyendra serves as full-time advisor to the Board of Directors of PharmaResearch Products Ltd. He has previously worked with licensing, alliances and business development for Daewoong Pharmaceutical Company Ltd. and established international distribution for Samyang’s medical devices and pharmaceutical business. Satyendra holds B. Pharm (Hons.) from the Birla Institute of Technology and Science in Pilani, India and a Ph.D. from Seoul National University in Seoul, Korea.

Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders: No.
Share Holding in Promore Pharma: No current holding.

Mrs. Marianne Dicander Alexandersson
Mrs. Marianne Dicander Alexandersson
Board Member since 2017

Born: 1959.

Marianne was previously CEO of Kronans Droghandel AB, Sjätte AP-fonden and Global Health Partner AB and deputy CEO of Apoteket. She holds an M.Sc. in Chemical Engineering from Chalmers Technical College in Gothenburg.

Other Assignments: Marianne serves as chairman of Sahlgrenska Science Park AB, board member and CEO of MDA Management AB, board member of Recipharm AB (publ), Enzymatica AB (publ), Praktikertjänst Aktiebolag, Camurus AB, AdderaCare AB and Xperentia AB.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders: Yes.
Share Holding in Promore Pharma: No current holding.

Mrs. Kerstin Valinder Strinnholm
Mrs. Kerstin Valinder Strinnholm
Board Member since 2019

Born: 1960.

Kerstin has been responsible for business development and business strategy at Nycomed (now Takeda) and previously held leading positions in marketing and business development at Astra and AstraZeneca. She holds a degree from the journalism program at the University of Gothenburg.

Other Assignments: Board member of Corline Biomedical AB (publ), Immunicum AB (publ), Camurus AB (publ), KVS Invest AB, Cavastor AB, Gedea Biotech AB and Klifo A/S.

Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders: Yes.
Share Holding in Promore Pharma: No current holding.

Holdings as of March 29, 2019.